On March 29, 2023, the preliminary bidding result of the eighth round of the national drug bulk-buying launched by the National Healthcare Security Administration was released. Zhaoke Pharmaceutical (Hefei) Company Limited, a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), participated in the bidding and its product Nadroparin Calcium Injection won […]
March 15, 2023, the Guangdong-Hong Kong-Macau Greater Bay Area New Direction for Economic Development Conference cum Gold Pilot Award 2022, co-organized by Hong Kong Trade Development Council (HKTDC) and Hong Kong Chamber of Commerce in Guangdong (HKCCGD) was successfully held in Shangri-La Hotel, Guangzhou. Guangzhou Zhaoke Lian Fa Pharmaceutical Limited, a subsidiary of Lee’s Pharmaceutical […]
Recently, the Hefei Municipal Government announced the result of the 8th Hefei City Industrial Achievements in Technology and Innovation. The development of Antiplatelet Thrombolysin by Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) was honoured with second prize. The representative of the Group attended the High-tech Industrial Development Zone Awards Ceremony and received […]
Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) attained again the Caring Company Award Logo by The Hong Kong Council of Social Service (HKCSS) for three consecutive years in recognition of its commitment to caring for the community, employees and environment. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
Treprostinil Injection, Teglutik® and Trittico®, the commercialized products of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) have been included for the first time into the updated National Reimbursement Drug List (the “NRDL”) issued by the China National Healthcare Security Administration on 18 January 2023 and will be officially implemented from 1 March […]
Hong Kong, December 22, 2022, the “STEM Experience Program for Secondary Students——Kanya Lee Scholarship Recognition Ceremony 2022” was successfully held in Hyatt Regency Hong Kong, Tsim Sha Tsui. Established in 2021, the Kanya Lee Scholarship Program, co-organized with Caritas School Social Work Service, aims at providing support to the secondary students with economic burden to […]
Hong Kong, December 14-17, 2022, the International Convention for Biotechnology in Hong Kong 2022 (BIOHK2022), co-organized by the Hong Kong Biotechnology Organization, BayHelix Group and Ausvic Capital was successfully held in the Hong Kong Convention and Exhibition Centre. As the first international biotech exhibition organized in Hong Kong, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or […]
Hong Kong, November 30, 2022, the Most Valuable Companies in Hong Kong (HKMVC) 2022 Awards Ceremony organized by Mediazone Group, a reputable international business magazine publisher was successfully held at the Royal Pacific Hotel, Tsim Sha Tsui. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) was honoured with the HKMVC 2022 award with […]
State Council announced the “General Plan of Nansha, Guangzhou for Deepening Globally Oriented Comprehensive Co-operation amongst Guangdong, Hong Kong and Macau” (Nansha Plan) in June 2022 and implemented taxation rate adjustment in Nansha recently. Dr. LI Xiaoyi, the Founder and Director of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) was interviewed by […]
The rare disease community has received increased public attention as Chinese authorities has issued a circular on further promoting the prevention and control measures, while strengthening the supportive care needs of patients with rare diseases. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), China Alliance for Rare Diseases, RDPAC, China Pharmaceutical Innovation and […]
Thai 
English